A naturalistic evaluation and audit database of agomelatine: clinical outcome at 12weeks

A. Sparshatt, R. H. McAllister Williams, D. S. Baldwin, P. M. Haddad, S. Bazire, E. Weston, P. Taylor, David Taylor

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Objective: To determine the effectiveness of agomelatine in routine clinical practice and explore factors associated with response and continuation.

Method: Consecutive patients prescribed agomelatine in participating psychiatric services were included. Patient demographic and outcome data were collected at treatment initiation and then at weeks 4, 8 and 12. Outcomes were analysed with respect to clinical and demographic factors.

Results: A total of 110 patients from nine NHS trusts were followed through 12 weeks of treatment. Agomelatine was largely used in difficult-to-treat or refractory patients: 83 (75%) had failed to respond to, or relapsed on, prior antidepressants. There were high rates of physical (54.5%) and psychiatric (50.0%) comorbidity. At 12 weeks of treatment, 68 (62%) continued agomelatine treatment. Overall, 69 subjects (62.7%) improved by at least one point of the Clinical Global Impression (severity) scale. Of 42 who discontinued, 23 (56%) discontinued because of lack of efficacy and 10 (24%) due to an adverse event. Of all variables examined, only a history of more than five episodes of depression significantly predicted discontinuation of treatment (OR continuation -0.36, 95% CI 0.14, 0.95).

Conclusion: Agomelatine was effective and generally well tolerated in a cohort of difficult-to-treat patients in clinical practice.

Original languageEnglish
Article numberN/A
Pages (from-to)203-211
Number of pages9
JournalActa Psychiatrica Scandinavica
Issue number3
Publication statusPublished - Sept 2013


  • agomelatine
  • depression
  • effectiveness
  • adverse effects


Dive into the research topics of 'A naturalistic evaluation and audit database of agomelatine: clinical outcome at 12weeks'. Together they form a unique fingerprint.

Cite this